In the other hand, PD non-motor symptoms are treated with cholinesterase inhibitors (donepezil and rivastigmine) and NMDA receptor antagonists (memantine) that exert beneficial effects in PD-associated dementia and cognitive dysfunctions (Jankovic and Tan, 2020). The gene discussed is BCHE; the disease is Parkinson disease.